Plague

recurring chest infections :: Article Creator What To Know About Pneumonia As Queen Camilla Recovers From Chest Infection Queen Camilla has been recovering from pneumonia over the last few weeks. (Getty Images) Being struck down by a chest infection can be very unpleasant and, in some cases, dangerous - particularly if it turns out to be pneumonia. The condition, usually caused by a viral or bacterial infection, isn't swift. Recovery can take up to four weeks, even for a healthy person. Babies, older people and those with heart or lung conditions are at risk of getting seriously ill from it. Recently, Queen Camilla revealed that the chest infection she had been suffering from over the last few weeks was pneumonia. She fell ill after the royal tour of Australia and Samoa that she embarked on with King Charles III, and was forced to pull out of a series of engagements, including the Remembrance Day service at the Cenotaph on Sunday 10 No...

renal tuberculosis symptoms :: Article Creator

bcg vaccine is for the prevention of :: Article Creator BCG: Can A Vaccine From 1921 Save Lives From Covid-19? BCG (Bacillus Calmette-Guerin) vaccine for tuberculosis, pictured at the Pasteur Institute in Paris in 1931. Scientists in the UK have begun testing the BCG vaccine, developed in 1921, to see if it can save lives from Covid. The vaccine was designed to stop tuberculosis, but there is some evidence it can protect against other infections as well. But while millions of people in the UK will have had the BCG jab as a child, it is thought they would need to be vaccinated again to benefit. Vaccines are designed to train the immune system in a highly targeted way that leaves lasting protection against one particular infection. But this process also causes wide-spread changes in the immune system. This seems to heighten the response to other infections and scientists hope it may even give our bodies an advantage...

granulomatous infection lung :: Article Creator Kinevant Sciences Announces Topline Results From Phase 2 RESOLVE-Lung Study Of Namilumab In Chronic Active Pulmonary Sarcoidosis Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON and NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) --  Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced its Phase 2 study failed to show treatment benefit in patients with chronic active pulmonary sarcoidosis. The Phase 2 RESOLVE-Lung study (NCT05314517) evaluated the efficacy and safety of namilumab, an investigational anti-GM-CSF monoclonal antibody administered once-monthly as a subcutaneous injection, in participants with chronic active pulmonary sarcoidosis. Primary Endpoint D...

botox is botulinum toxin :: Article Creator When Is The Right Time For Botox? Expert Shares A Guide To Timing And Treatment Taking care of your skin is a personal journey, and for many, Botox has become a go-to option to maintain a youthful glow. Whether you're hoping to smooth out those early signs of ageing or treat other concerns like migraines or excessive sweating, Botox can offer some impressive benefits. But knowing when to start, and when to stop, can be a bit tricky. Is there a perfect age to try it? What if you're already noticing fine lines or wrinkles? And when should one stop it? To help demystify these questions, Dr Vidushi Jain, Dermatologist and Medical Head, Dermalinks, Noida and Ghaziabad, explains what Botox is, how it works, and how to determine the right timing for your unique needs. What is Botox? "Botox is a shorthand term for botulinum toxin, which is produced by the bacterium Clostridium botulinum. When...